Methyl N-cyano-4-morpholinecarbimidothioate | 55843-68-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: Methyl N-cyano-4-morpholinecarbimidothioate
• CAS: 55843-68-0
• 化学式: C₇H₁₁N₃OS
• 分子量: 185.25
• InChiKey: STUDYASYNMISQR-CLFYSBASSA-N

物化性质

• 沸点：
  300.5±52.0 °C(Predicted)
• 密度：
  1.24±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.52
• 重原子数：
  12.0
• 可旋转键数：
  0.0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  48.62
• 氢给体数：
  0.0
• 氢受体数：
  4.0

反应信息

• 作为反应物：
  描述：

  Methyl N-cyano-4-morpholinecarbimidothioate 、 lithium diisopropyl amide 以33%的产率得到
  参考文献：
  名称：

  YOKOYAMA MASATAKA; KURAUCHI MASAHIKO; IMAMOTO TSUNEO, TETRAHEDRON LETT., 1981, 22, NO 24, 2285-2288

  摘要：

  DOI：
• 作为产物：
  描述：

  N-氰亚胺基-S,S-二硫代碳酸二甲酯 、 吗啉 以 N,N-二甲基甲酰胺 为溶剂， 反应 1.0h， 生成 Methyl N-cyano-4-morpholinecarbimidothioate
  参考文献：
  名称：

  Synthesis of substituted [1,3]thiazolo[4,5-b]pyridines and [1,3]thiazolo[4,5-d][1,2,3]triazines

  摘要：

  In this work, we described an easy preparation Of substituted 4-amino-5-cyano-1,3-thiazoles. These compounds have been used as starting materials to obtain two classes of compounds. New substituted [1,3]thiazolo[4,5-e]pyridines were synthesized in one step via Friedlander reaction. Diazotation of 4-amino-5-cyano-1,3-thiazoles afforded 4-chloro[1,3]thiazolo[4,5-d][1,2,3]triazines in one step. The later Was substituted by a secondary amine to obtain substituted 4-amino[1,3]thiazolo[4,5-d][1,2,3]triazines. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2008.07.017

文献信息

• [EN] THIAZOLOPYRIMIDINONE DERIVATIVES AS PI3 KINASE INHIBITORS<br/>[FR] DÉRIVÉS DE THIAZOLOPYRIMIDINONE COMME INHIBITEURS DE LA KINASE PI3
  申请人：GLAXOSMITHKLINE LLC

  公开号：WO2010135504A1

  公开（公告）日：2010-11-25

  This invention relates to the use of thiazolopyrimidinone derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3' OH kinase family (hereinafter PI3 kinases), suitably, PI3Kα, PI3Kδ, PI3Kβ, and/or PI3Kγ. Suitably, the present invention relates to the use of thiazolopyrimidinones in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3Kβ selective thiazolopyrimidinones compounds for treating cancer.

  这项发明涉及噻唑吡咯嘧啶酮衍生物在调节磷脂酰肌醇3' OH激酶家族（以下简称PI3激酶）的活性或功能，特别是抑制其活性或功能方面的用途，适当地，PI3Kα、PI3Kδ、PI3Kβ和/或PI3Kγ。适当地，本发明涉及噻唑吡咯嘧啶酮在治疗以下一种或多种疾病状态中的用途：自身免疫性疾病、炎症性疾病、心血管疾病、神经退行性疾病、过敏、哮喘、胰腺炎、多器官功能衰竭、肾脏疾病、血小板聚集、癌症、精子活动力、移植排斥、移植物排斥和肺部损伤。更适当地，本发明涉及PI3Kβ选择性噻唑吡咯嘧啶酮化合物用于治疗癌症。
• CXCR2 inhibitors
  申请人：Press Neil John

  公开号：US20100069407A1

  公开（公告）日：2010-03-18

  The present invention relates to compounds of formula (I) and the use of these compounds as pharmaceuticals, e.g. in preventing or treating a CXCR2 receptor mediated condition or disease.

  本发明涉及式(I)化合物及其作为药物的使用，例如在预防或治疗CXCR2受体介导的疾病或病症中的应用。
• THIAZOLOPYRIMIDINONE DERIVATIVES AS PI3 KINASE INHIBITORS
  申请人：Lin Hong

  公开号：US20120053147A1

  公开（公告）日：2012-03-01

  This invention relates to novel compounds of formula (I): and derivatives thereof useful for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3′ OH kinase family (hereinafter PI3 kinases), suitably, PI3Kα, PI3K}, PI3Kβ, and/or PI3Kγ.

  本发明涉及公式（I）的新化合物及其衍生物，可用于调节磷脂酰肌醇3′ OH激酶家族（以下简称PI3激酶）的活性或功能，特别是适用于PI3Kα，PI3K}，PI3Kβ和/或PI3Kγ的抑制。
• HETEROAROMATIC RING COMPOUNDS
  申请人：Sumitomo Pharmaceuticals Company, Limited

  公开号：EP1201661A1

  公开（公告）日：2002-05-02

  Heteroaromatic ring compounds or pharmaceutically acceptable salts thereof, which have excellent characteristics and have strong curative effects to immuno-imbalance and choronic inflammation. Representative is the compound of the formula:

  杂芳香环化合物或其药学上可接受的盐类，具有优良的特性，对免疫平衡和络脉炎症有很强的疗效。具有代表性的是式中的化合物：
• EP1201661
  申请人：——

  公开号：——

  公开（公告）日：——